SOURCE: Yasheng Group

September 27, 2005 09:00 ET

YaSheng Group Announces Plans of Application Use for Lysozyme

REDWOOD CITY, CA -- (MARKET WIRE) -- September 27, 2005 -- The YaSheng Group (OTC: YHGG) Academy of Science Research and Development Center has reported a more detailed list of applications of its Human Lysozyme DNA Technology.

The company has plans to offer lysozyme in a variety of applications with the initial introduction targeted at the food industry as a food additive for baby foods and food preservation such as the production of cheese and wine. In addition, medical uses of lysozyme will be applied in medicine in various forms such as tablet, capsule, eye drops and oral drops. Household chemicals such as toothpaste and cosmetics will also be introduced. Furthermore, YaSheng has plans to apply the lysozyme technology in agriculture to improve the variety of crops and develop resistance against disease in fruits and vegetables.

"Our Human Lysozyme Technology marks a significant milestone for the YaSheng Group. We are investing in a new facility and will continue to work with various departments on an International level to gain approval and adoption," a company spokesperson said.

About YaSheng Group:

The YaSheng Group (OTC: YHGG) is a diversified industrial conglomerate incorporated in Redwood City, California, and operates in hi-tech agriculture, salt chemistry and biological technology as its core business with advantages in rich land, mineral resources, capital and technology reserves.

Through its 136 subsidiaries, the company operating categories include: chemical engineering, agricultural production, biotech, pharmaceuticals, textile products, printing and dyeing, commercial trading, beverages and inorganic salt manufacturing. With total assets of approximately $1.5 billion USD and over 15,000 employees, YaSheng Group has 155,097,355 shares issued and outstanding as of December 1, 2004.

Further information concerning YaSheng Group can be found on the corporate website:

Forward-Looking Statements:

Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.

Contact Information